Abstract
The evidence of a close relationship between cardiovascular disease and erectile dysfunction (ED) is well documented. The aim of this study is to investigate whether there is an early asymptomatic impairment of the peripheral vasculature in young ED patients without obvious cardiovascular disease. We studied a total of 261 ED patients (19–40 years old) and 40 age-matched healthy controls. All participants received questionnaires of cardiovascular risk factors and erectile function assessment, were subjected to lab tests of fasting blood sample, and underwent the ultrasonographic examination of brachial artery flow-mediated dilation (FMD) and carotid intima-media thickness (c-IMT). Insulin resistance (IR) was measured by the homeostasis model assessment of insulin resistance (HOMA-IR). Compared with normal human controls, FMD was significantly lower, whereas the average c-IMT was significantly greater in ED patients. An inverse correlation was found between FMD and mean c-IMT. The ED patients had significantly higher levels of fasting glucose, fasting insulin and HOMA-IR index, but showed relatively lower total testosterone and prolactin levels than the controls. Both FMD and c-IMT showed a significant correlation with International Index of Erectile Function-5 questionnaire (IIEF-5) score, age and HOMA-IR. Multivariate stepwise regression analysis demonstrated that age, HOMA-IR and IIEF-5 score were the risk factors associated with FMD and c-IMT. In conclusion, young ED patients in association with IR display diminished FMD and increased c-IMT. Furthermore, ED, HOMA-IR and age are independent predictors of the two subclinical atherosclerotic markers.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hatzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichristou D, Montorsi F et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol 2010; 57: 804–814.
Capogrosso P, Colicchia M, Ventimiglia E, Castagna G, Clementi MC, Suardi N et al. One patient out of four with newly diagnosed erectile dysfunction is a young man—worrisome picture from the everyday clinical practice. J Sex Med 2013; 10: 1833–1841.
Ni H, Coady S, Rosamond W, Folsom AR, Chambless L, Russell SD et al. Trends from 1987 to 2004 in sudden death due to coronary heart disease: the atherosclerosis risk in communities (ARIC) study. Am Heart J 2009; 157: 46–52.
Vlachopoulos C, Ioakeimidis N, Terentes-Printzios D, Stefanadis C . The triad: erectile dysfunction-endothelial dysfunction-cardiovascular disease. Curr Pharm Des 2008; 14: 3700–3714.
Kaiser DR, Billups K, Mason C, Wetterling R, Lundberg JL, Bank AJ . Impaired brachial artery endothelium-dependent and-independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol 2004; 43: 179–184.
Schipilliti M, Caretta N, Palego P, Selice R, Ferlin A, Foresta C . Metabolic syndrome and erectile dysfunction: the ultrasound evaluation of cavernosal atherosclerosis. Diabetes Care 2011; 34: 1875–1877.
Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moinpour CM, Coltman CA . Erectile dysfunction and subsequent cardiovascular disease. JAMA 2005; 294: 2996–3002.
Montorsi P, Ravagnani PM, Galli S, Rotatori F, Veglia F, Briganti A et al. Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. Eur Heart J 2006; 27: 2632–2639.
Vardi Y, Dayan L, Apple B, Gruenwald I, Ofer Y, Jacob G . Penile and systemic endothelial function in men with and without erectile dysfunction. Eur Urol 2009; 55: 979–985.
Miner M, Nehra A, Jackson G, Bhasin S, Billups K, Burnett AL et al. All men with vasculogenic erectile dysfunction require a cardiovascular workup. Am J Med 2014; 127: 174–182.
Montorsi P, Montorsi F, Schulman CC . Is erectile dysfunction the "tip of the iceberg" of a systemic vascular disorder? Eur Urol 2003; 44: 352–354.
Chiurlia E, D'Amico R, Ratti C, Granata AR, Romagnoli R, Modena MG . Subclinical coronary artery atherosclerosis in patients with erectile dysfunction. J Am Col Cardiol 2005; 46: 1503–1506.
Ucar G, Secil M, Demir O, Demir T, Comlekci A, Uysal S et al. The combined use of brachial artery flow-mediated dilatation and carotid artery intima-media thickness measurements may be a method to determine vasculogenic erectile dysfunction. Int J Impot Res 2007; 19: 577–583.
Averbeck MA, Colares C, de Lira GH, Selbach T, Rhoden EL . Evaluation of endothelial function with brachial artery ultrasound in men with or without erectile dysfunction and classified as intermediate risk according to the Framingham score. J Sex Med 2012; 9: 849–856.
Javaroni V, Queiroz-Miguez M, Abreu-Casanova M, Oigman W, Neves MF . Brachial flow-mediated dilation correlates with vardenafil response in hypertensive men with vasculogenic erectile dysfunction. Urology 2011; 78: 368–374.
Caretta N, Palego P, Ferlin A, Garolla A, Bettella A, Selice R et al. Resumption of spontaneous erections in selected patients affected by erectile dysfunction and various degrees of carotid wall alteration: role of tadalafil. Eur Urol 2005; 48: 326–331; discussion 331–322.
Cappelleri JC, Rosen RC . The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience. Int J Impot Res 2005; 17: 307–319.
Farin HM, Abbasi F, Reaven GM . Body mass index and waist circumference both contribute to differences in insulin-mediated glucose disposal in nondiabetic adults. Am J Clin Nutr 2006; 83: 47–51.
Chou HH, Hsu LA, Liu CJ, Teng MS, Wu S, Ko YL . Insulin resistance is associated with C-reactive protein independent of abdominal obesity in nondiabetic Taiwanese. Metabolism 2010; 59: 824–830.
Yan RT, Anderson TJ, Charbonneau F, Title L, Verma S, Lonn E . Relationship between carotid artery intima-media thickness and brachial artery flow-mediated dilation in middle-aged healthy men. J Am Coll Cardiol 2005; 45: 1980–1986.
Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE . Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam study. Circulation 1997; 96: 1432–1437.
Sun Y, Lin CH, Lu CJ, Yip PK, Chen RC . Carotid atherosclerosis, intima media thickness and risk factors-an analysis of 1781 asymptomatic subjects in Taiwan. Atherosclerosis 2002; 164: 89–94.
Kim J, Chae YK, Chernoff A . The risk for coronary heart disease according to insulin resistance with and without type 2 diabetes. Endocr Res 2013; 38: 195–205.
Karrowni W, Li Y, Jones PG, Cresci S, Abdallah MS, Lanfear DE et al. Insulin resistance is associated with significant clinical atherosclerosis in nondiabetic patients with acute myocardial infarction. Arterioscl Throm Vasc Biol 2013; 33: 2245–2251.
Deanfield J, Donald A, Ferri C, Giannattasio C, Halcox J, Halligan S et al. Endothelial function and dysfunction. Part i: Methodological issues for assessment in the different vascular beds: a statement by the working group on endothelin and endothelial factors of the European Society of Hypertension. J Hypertens 2005; 23: 7–17.
Green DJ, Jones H, Thijssen D, Cable NT, Atkinson G . Flow-mediated dilation and cardiovascular event prediction: does nitric oxide matter? Hypertension 2011; 57: 363–369.
Bhatia T, Kapoor A, Kumar J, Sinha A, Ranjan P, Kumar S et al. Impaired flow-mediated vasodilatation in Asian Indians with erectile dysfunction. Asian J Androl 2013; 15: 652–657.
Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M . Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007; 115: 459–467.
Vlachopoulos C, Aznaouridis K, Ioakeimidis N, Rokkas K, Tsekoura D, Vasiliadou C et al. Arterial function and intima-media thickness in hypertensive patients with erectile dysfunction. J Hypertens 2008; 26: 1829–1836.
Gokkaya CS, Aktas BK, Toprak U, Yahsi S, Bulut S, Ozden C et al. Is there a concordance between carotid and penile cavernosal artery intima-media thickness in patients with erectile dysfunction? Int J Impot Res 2012; 24: 44–48.
Ponholzer A, Stopfer J, Bayer G, Susani M, Steinbacher F, Herbst F et al. Is penile atherosclerosis the link between erectile dysfunction and cardiovascular risk? An autopsy study. Int J Impot Res 2012; 24: 137–140.
Dong JY, Zhang YH, Qin LQ . Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol 2011; 58: 1378–1385.
Inman BA, Sauver JL, Jacobson DJ, McGree ME, Nehra A, Lieber MM et al. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc 2009; 84: 108–113.
Chew KK, Finn J, Stuckey B, Gibson N, Sanfilippo F, Bremner A et al. Erectile dysfunction as a predictor for subsequent atherosclerotic cardiovascular events: findings from a linked-data study. J Sex Med 2010; 7: 192–202.
Vlachopoulos CV, Terentes-Printzios DG, Ioakeimidis NK, Aznaouridis KA, Stefanadis CI . Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies. Circ Cardiovasc Qual Outcomes 2013; 6: 99–109.
Lupattelli G, Vuono SD, Boni M, Helou R, Mannarino MR, Roscini AR et al. Insulin resistance and not bmi is the major determinant of early vascular impairment in patients with morbid obesity. J Atheroscler Thromb 2013; 20: 924–933.
Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R et al. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 1996; 93: 1809–1817.
Bansilal S, Farkouh ME, Fuster V . Role of insulin resistance and hyperglycemia in the development of atherosclerosis. Am J Cardiol 2007; 99: 6B–14B.
Karrowni W, Li Y, Jones PG, Cresci S, Abdallah MS, Lanfear DE et al. Insulin resistance is associated with significant clinical atherosclerosis in nondiabetic patients with acute myocardial infarction. Arterioscl Thromb Vasc Biol 2013; 33: 2245–2251.
Rey-Valzacchi GJ, Costanzo PR, Finger LA, Layus AO, Gueglio GM, Litwak LE et al. Addition of metformin to sildenafil treatment for erectile dysfunction in eugonadal nondiabetic men with insulin resistance. A prospective, randomized, double-blind pilot study. J Androl 2012; 33: 608–614.
Labazi H, Wynne BM, Tostes R, Webb RC . Metformin treatment improves erectile function in an angiotensin II model of erectile dysfunction. J Sex Med 2013; 10: 2154–2164.
Acknowledgements
The work is supported by grants from the National Natural Science Foundation of China (Grant No. 81070488, 81270696, 81302223), Guangdong Natural Science Fund ((Grant No.S2013010015356, S2011010005282, 2015A030310083) and Science and Technology Planning Project of Guangzhou, China (Grant No. 201300000094, 2012B 031800288, 2011B032000003). The funder had no role in study design, data collection and analysis,decision to publish,or preparation of the manuscript.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Chen, SF., Yao, FJ., Sun, XZ. et al. Brachial artery flow-mediated dilatation and carotid intima-media thickness in young ED patients with insulin resistance. Int J Impot Res 28, 194–199 (2016). https://doi.org/10.1038/ijir.2016.30
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijir.2016.30
This article is cited by
-
Carotid artery intima-media thickness can predict the response of patients with erectile dysfunction to phosphodiesterase 5 inhibitors
International Journal of Impotence Research (2019)
-
Young at heart? ED linked to CVD
Nature Reviews Urology (2016)